Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2000-0.1300 (-5.58%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-1,575
-1,575
-7,382
-4,107
-4,766
Depreciation & amortisation
214
214
351
252
208
Stock-based compensation
1,052
1,052
982
1,259
779
Change in working capital
830
830
432
883
-3,493
Accounts receivable
-221
-221
357
-278
-333
Inventory
387
387
765
296
-2,762
Accounts payable
133
133
-593
908
-538
Other working capital
752
752
-3,371
-1,453
-7,142
Other non-cash items
-
-
353
321
97
Net cash provided by operating activities
827
827
-3,234
-1,417
-6,903
Cash flows from investing activities
Investments in property, plant and equipment
-75
-75
-137
-36
-239
Acquisitions, net
-
-
-
-
0
Other investing activities
-
-
-
-49
-
Net cash used for investing activities
-75
-75
-137
-85
-239
Cash flows from financing activities
Debt repayment
-79
-79
-286
-264
-800
Common stock issued
-
-
-
0
11,452
Other financing activities
-
-
157
-
-85
Net cash used provided by (used for) financing activities
-79
-79
34
237
11,216
Net change in cash
673
673
-3,339
-1,276
4,083
Cash at beginning of period
3,634
3,634
6,973
8,249
4,166
Cash at end of period
4,307
4,307
3,634
6,973
8,249
Free cash flow
Operating cash flow
827
827
-3,234
-1,417
-6,903
Capital expenditure
-75
-75
-137
-36
-239
Free cash flow
752
752
-3,371
-1,453
-7,142